drugset / Trial / NCT04393415

Using PRP and Cord Blood in Treatment of Covid -19

NCT04393415

Unknown 100 enrolled Aljazeera Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

covid - 19 is a critical viral infection that affects humans

Timeline

Start
2020-05-25
Primary completion
2020-08-25
Completion
2020-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy